Elite Pharmaceuticals, Inc. (ELTP) Total assets 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) total assets at each fiscal year-end, per SEC filings.
$138.3MFY2026 · since FY2017: $34.3M → $138.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $138.3M | +43.5% |
| FY2025 | $96.4M | +15.2% |
| FY2024 | $83.7M | +104.6% |
| FY2023 | $40.9M | +16.4% |
| FY2022 | $35.1M | +34.2% |
| FY2021 | $26.2M | +4.9% |
| FY2020 | $25.0M | +2.3% |
| FY2019 | $24.4M | -21.0% |
| FY2018 | $30.9M | -10.0% |
| FY2017 | $34.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTP financial trends
ELTP RevenueELTP Net incomeELTP Net marginELTP Gross profitELTP Gross marginELTP Operating incomeELTP Operating marginELTP Operating cash flowELTP Free cash flowELTP Capital expendituresELTP Return on equityELTP Stock buybacksELTP Dividends paidELTP Total liabilitiesELTP Shareholders’ equityELTP overview →